Recent Advances in Novel Modulators for Cardiac Myosin Disorders
In advanced stages of heart disease, most cases are characterized by heart failure, where the heart's systolic and diastolic functions are weakened, and then it cannot meet the body's normal oxygen demands. The contraction of the heart, at the molecular level, involves the interaction betw...
Saved in:
| Main Authors: | Hancheng Wang, Mengfei Wang, Bo Han, Qiushi Chen, Qingwei Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Georg Thieme Verlag KG
|
| Series: | Pharmaceutical Fronts |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/a-2646-1097 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Mavacamten on Echocardiographic Features in Chinese Patients with Obstructive Hypertrophic Cardiomyopathy: Results from the EXPLORER-CN Study
by: Zhuang Tian, et al.
Published: (2025-04-01) -
Considering the effect of Pi rebinding on myosin dynamics based on the distinct functions of cardiac and skeletal myosin
by: Motoshi Kaya
Published: (2025-05-01) -
Diagnostic Challenges and Management of Hypertrophic Cardiomyopathy with Left Ventricular Outflow Tract Obstruction in a Patient with Hypertension
by: Nina Marta Kubikowska, et al.
Published: (2025-04-01) -
An ALPK3 truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamten
by: Lisa Leinhos, et al.
Published: (2025-03-01) -
Hypertrophic cardiomyopathy occurred after successful surgical correction of supravalvular aortic stenosis: a case report of Williams–Beuren syndrome
by: Hongxiao Yu, et al.
Published: (2025-08-01)